261.77 USD
▲+4.65+1.81%
盘后 261.37 -0.15%
2026-09-14
市值
$464.82B
市盈率
74.31
EPS
3.54
股息率
2.63%
52 周区间
190.75 – 267.47
成交量
4.51M
Beta
0.28
目标价
277.31
52W 低 190.7552W 高 267.47
价格走势
公司简介
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medi...
关联新闻
- Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze.
Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.